Brief: Interpace Biosciences Q4 Revenue USD 9.224 Million
30/03/2026 21:01
Mar 30 (Reuters) - Interpace Biosciences Q4 operating income USD 1.577 million. Q4 gross profit USD 6.044 million Q4 operating expenses USD 4.467 million Q4 net income USD 22.657 million